Although this article is focused on start-ups and VC capital, the insights are very applicable to the hedge fund and alternative asset capital raising.    Many of us have experienced exactly what the”Biotech Rebel” has faced.     Enjoy!!    Dave   From CNBC    Biotech rebel’: Here’s what it’s really like to raise money in...Read More